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Neisseria gonorrhoeae becomes resistant to tetracycline by two major mechanisms: expression of a plasmid-
encoded TetM protein and mutations in endogenous genes (chromosomally mediated resistance). Early studies
by Sparling and colleagues (P. F. Sparling F. A. J. Sarubbi, and E. Blackman, J. Bacteriol. 124:740–749, 1975)
demonstrated that three genes were involved in high-level chromosomally mediated tetracycline resistance
(MIC of tetracycline > 2 g/ml): ery-2 (now referred to as mtrR), penB, and tet-2. While the identities of the first
two genes are known, the tet-2 gene has not been identified. We cloned the tet-2 gene, which confers tetracycline
resistance, from tetracycline-resistant clinical isolate N. gonorrhoeae FA6140 and show that resistance is due
to a single point mutation (Val-57 to Met) in the rpsJ gene (rpsJ1) encoding ribosomal protein S10. Moreover,
the identical mutation was found in six distinct tetracycline-resistant clinical isolates in which the MIC of
tetracycline was >2 g/ml. Site-saturation mutagenesis of the codon for Val-57 identified two other amino
acids (Leu and Gln) that conferred identical levels of resistance as the Met-57 mutation. The mutation maps
to the vertex of a loop in S10 that is near the aminoacyl-tRNA site in the structure of the 30S ribosomal subunit
from Thermus thermophilus, and the residue equivalent to Val-57 in T. thermophilus S10, Lys-55, is within 8 to
9 Å of bound tetracycline. These data suggest that large noncharged amino acids alter the rRNA structure near
the tetracycline-binding site, leading to a lower affinity of the antibiotic.
Neisseria gonorrhoeae, the etiological agent for the sexually
transmitted infection gonorrhea, is responsible for nearly
350,000 infections each year (7). One of the hallmarks of N.
gonorrhoeae is its ability to become resistant to many of the
drugs used to treat infections. For example, both penicillin and
tetracycline used to be prescribed routinely to treat gonococcal
infections, but increasing resistance to these antimicrobials
eventually led to their discontinuation. The antibiotics cur-
rently recommended for the treatment of gonococcal infec-
tions are the -lactam antibiotics ceftriaxone and cefixime and
the fluoroquinolones ciprofloxacin, ofloxacin, and levofloxacin
(8). Recently, however, the increasing prevalence of fluoro-
quinolone resistance in gonococcal infections on the West
Coast and in certain patient populations (i.e., men who have
sex with men) has necessitated the Centers for Disease Control
and Prevention to recommend that fluoroquinolones not be
used to treat gonococcal infections in these areas or in men
who have sex with men (5, 6).
Two types of resistance to penicillin and tetracycline are
found in N. gonorrhoeae: plasmid-mediated resistance and
chromosomally mediated acquisition of mutated genes or loci
(30). Plasmid-mediated resistance to penicillin and tetracycline
is due to the production of a -lactamase (27) and the TetM
protein (23), respectively. For chromosomally mediated resis-
tance, resistance genes are mutated versions of normal, endog-
enous genes such that each mutant gene incrementally in-
creases resistance to the antibiotic until treatment failure
occurs. These resistance determinants can be transferred, of-
ten in a specific order, from a resistant strain to a recipient
susceptible strain by DNA transformation and homologous
recombination.
The mechanisms of chromosomally mediated penicillin re-
sistance are complicated and not completely understood. For
example, at least four resistance determinants are involved in
chromosomally mediated high-level penicillin resistance (de-
fined as a penicillin MIC  2 mg/ml): (i) the penA determinant,
which encodes mutations in PBP 2 that decrease its rate of
acylation by penicillin (31); (ii) the mtrR locus, which is a
single-base-pair deletion in the promoter for the mtrR repres-
sor that results in the overexpression of the MtrC-MtrD-MtrE
efflux pump (14, 26); (iii) the penB determinant, which encodes
mutations in the PIB outer membrane porin (13, 24); and (iv)
the ponA determinant, which encodes a mutation in PBP 1
that, like penA, decreases its rate of acylation by penicillin (28).
In addition, at least one other gene is involved in high-level
penicillin resistance, but its identity has remained elusive.
In contrast to penicillin resistance, the mechanisms of chro-
mosomally mediated tetracycline resistance are more straight-
forward. Sparling and colleagues (30) showed that tetracycline
resistance of an antibiotic-susceptible strain such as FA19
could be increased to intermediate levels (tetracycline MIC
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[MICtet]  1 g/ml) following transformation with the mtrR
(previously known as ery-2) and penB resistance determinants
from a chromosomally mediated penicillin- and tetracycline-
resistant N. gonorrhoeae (CMRNG) clinical isolate. High-level
resistance to tetracycline at the same MIC as that in the donor
strain could be obtained by transformation of an additional
resistance determinant, termed tet-2, but its identity was not
determined.
We report here on the identification of the tet-2 gene (re-
named rpsJ1) as a Val-57-to-Met point mutation in the rpsJ
gene encoding ribosomal protein S10. Our results indicate that
this mutation is widespread in chromosomally mediated tetra-
cycline-resistant strains and that other large, noncharged
amino acids afford identical levels of resistance as the Met-57
mutation. Examination of the 3-Å structure of the 30S ribo-
somal subunit from Thermus thermophilus bound with tetracy-
cline (3) indicated that the mutation maps to the vertex of a
loop in the S10 protein that projects toward the aminoacyl-
tRNA site of the small subunit and is within 8 to 9 Å of the
antibiotic. Although the amino acid appears to be too far from
the antibiotic to have a direct effect on binding, these data
suggest that the mutation modulates the rRNA-binding site for
tetracycline, thus lowering the affinity of the antibiotic for the
ribosome.
MATERIALS AND METHODS
Bacterial strains and plasmids. FA19 (a tetracycline-susceptible strain with an
MICtet  0.25 g/ml) and FA6140 (with an MICtet  4 g/ml) have been
described previously and were obtained from Fred Sparling, University of North
Carolina at Chapel Hill (10, 21). Construction of PR100 (FA19 penA mtrR penB)
was described previously (28). Clinical isolates of N. gonorrhoeae in which the
MIC of tetracycline was 2 g/ml (but 8 g/ml) were obtained from several
sources. Strains 10026, 10030, L2313, L4617, and L9715 were kindly provided by
Marcia Hobbs, University of North Carolina at Chapel Hill, and were from a
Wilson County, North Carolina, surveillance program (12, 16). Sequence analysis
of the mtr and por gene regions indicated that these strains had frameshift
mutations in the mtrR transcriptional regulator and penB mutations at residues
120 and 121 of the por gene. Strains 111, 114, and 131, each of which had the
mtrR promoter mutation and penB mutations at residues 120 and 121 of the por
gene, were obtained from Joan Knapp at the Centers for Disease Control and
Prevention. MS11 was kindly provided by Janne Cannon, University of North
Carolina at Chapel Hill. pMH-S10*, which was pUC18 containing the entire
coding sequence of S10 with the Val-57-to-Met mutation and a 155-bp down-
stream sequence that included a tandem repeat of the Neisseria 10-bp uptake
sequence (11), was used to transfer the rpsJ1 gene to susceptible strains (Table 1).
Transformation of N. gonorrhoeae was carried out by standard methods (24, 28).
Growth conditions and MIC determinations. N. gonorrhoeae was grown on GC
medium base (GCB) plates (Difco/BD, Franklin Lakes, NJ) with supplements I
and II (19) at 37°C in a humidified 5% CO2–95% air atmosphere. Escherichia coli
was cultured on Luria broth plates or in 2x YT medium. MICs were determined
by the spot method, as described previously (28). Briefly, cells were grown on
GCB plates and resuspended in GCB broth with supplements I and II and 10
mM MgCl2 at an optical density at 600 nm of 1  107 cells/ml, and 5-l aliquots
were spotted onto GCB plates containing increasing concentrations of tetracy-
cline. The MIC was defined as the lowest concentration at which no more than
five colonies grew following incubation for 24 h. At least two to four individual
colonies from each transformation were tested. The MICs were identical in
individual colonies from each transformation and in separate experiments over
several days.
Cloning of the tet-2 (rpsJ1) gene from FA6140. To isolate the tet-2 gene,
chromosomal DNA from CMRNG strain FA6140 was digested with ApoI, which
produces a 5-AATT overhang that can be ligated into an EcoRI site, and size
fractionated on a 0.7% agarose gel. Ten fractions of ApoI fragments ranging in
size from 0.5 to 6 kb were purified from the gel and tested for their ability to
transform PR100 to tetracycline resistance on GCB plates containing 2 g/ml
tetracycline. DNA fragments from a size fraction between 1.4 and 1.8 kb gave the
highest transformation frequencies, and these were used to create a minilibrary
in the EcoRI-digested pMH2 vector. pMH2 contained the origin of replication
from pACYC177 (9) and the multiple-cloning site from pUC18. Nine hundred
sixty clones were transferred into 10 96-well plates, and plasmids isolated from 10
cultures, each of which contained all of the clones from 1 of the 10 plates, were
used in the transformation assay. Of the original 10 cultures examined, 5 gave
rise to high numbers of resistant colonies following transformation. Similar
experiments with cultures grown from a single plate eventually resulted in the
identification of a plasmid capable of transforming PR100 to tetracycline resis-
tance at a high frequency.
Identification of rpsJ alleles in tetracycline-resistant clinical isolates. The rpsJ
genes from a set of tetracycline-resistant clinical strains were amplified by PCR
with primers flanking the gene. Single colonies of each strain were diluted into
25 l water, boiled for 5 min, and centrifuged at top speed for 5 min. A 1-l
aliquot was used as the template in the PCR with rpsJ gene-specific primers. PCR
products were purified with a PCR purification kit (Marligen, Gaithersburg,
MD) and submitted directly for sequencing by the University of North Carolina
sequencing facility.
Random mutagenesis of codon 57 in rpsJ. Random mutagenesis of codon 57
was accomplished by overlap-extension PCR as described previously (15, 24).
The sense mutagenic primer (5-AACATTTTGCGTTCTCCGCACNNNAACA
AAACTTCCCGTGAACAA-3) comprised 21 bp preceding codon 57, 3 random
bases, and 20 bp following codon 57, while the antisense primer (5-GTGCGG
AGAACGCAAAATGTT-3) was complementary to the first 21 bp of the sense
primer. pMH-S10 was used as a template. In the first set of reactions, a sense
vector primer (relative to the direction of the rpsJ gene) and the antisense
mutagenic primer or the sense mutagenic primer and an antisense vector primer
were used to amplify the same template in separate amplification reactions. The
resulting fragments were isolated and combined, and the full-length rpsJ gene
with a randomized codon 57 was amplified in a second PCR to which only the
vector primers were added. The resulting mutant fragments were purified and
either used directly in a transformation reaction or subcloned into pUC18 to
TABLE 1. Strains and plasmids used in this study
Strain Description Selection agent(concn [g/ml])
pMH-S10* pUC18 containing the rpsJ1 allele from FA6140
pUC18-pilQ2 pUC18 containing bp 1333 to 2196 of pilQ2 and an additional 300 bp of downstream
sequence (39)
FA19 Tetracycline-susceptible laboratory strain
FA6140 CMRNG clinical isolate
FA19 penA4 FA19 transformed with FA6140 DNA Penicillin G (0.016)
FA19 penA4 rpsJ1 FA19 penA4 transformed with pMH-S10* Tetracycline (0.37)
FA19 penA4 mtrR FA19 penA4 transformed with FA6140 DNA Erythromycin (0.5)
FA19 penA mtrR rpsJ1 FA19 penA4 mtrR transformed with pMH-S10* Tetracycline (0.37)
PR100 FA19 penA4 mtrR transformed with FA6140 DNA; same as FA19 penA4 mtrR penB2 Tetracycline (0.37)
PR100 rpsJ1 PR100 transformed with pMH-S10* Tetracycline (2.0)
PR100 pilQ2 PR100 transformed with pUC18-pilQ2 Penicillin G (1.2)
PR100 pilQ2 rpsJ1 PR100 pilQ2 transformed with pMH-S10* Tetracycline (3.0)
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generate a minilibrary of mutant fragments. Sequencing of the PCR fragment or
the minilibrary revealed the presence of 4 bases of roughly equal intensity at each
of the three positions of the codon. Resistant transformants were passaged, and
the rpsJ gene was amplified from genomic DNA and submitted to DNA sequenc-
ing.
RESULTS
Cloning of the tet-2 gene. Previous data from Sparling and
coworkers demonstrated that chromosomally mediated tetra-
cycline resistance could be transferred from a CMRNG strain
to a susceptible strain by transformation and selection (30).
One of the genes identified in the prior study, termed tet-2, was
specific for tetracycline resistance, but its identity was not de-
termined. To clone the tet-2 gene, we created a minilibrary of
size-fractionated ApoI fragments (between 1.4 and 1.8 kb)
from genomic DNA isolated from the CMRNG strain FA6140
(MICtet  4 g/ml) (10) and isolated clones capable of trans-
forming PR100 (FA19 penA4 mtrR penB2) to high-level tetra-
cycline resistance (see Materials and Methods for more de-
tails). Five clones were identified, each of which contained an
identical 1,554-bp fragment encompassing a portion of the tufA
gene (encoding Ef-Tu) and the entire rpsJ gene encoding ri-
bosomal protein S10. PCR amplification and transformation
confirmed that the rpsJ gene conferred tetracycline resistance,
and sequencing of the rpsJ gene from each of the five clones
revealed an identical G-to-A point mutation at codon 57 that
changed Val to Met (Fig. 1).
Unexpectedly, the rpsJ sequence of MS11 (GenBank acces-
sion number L36380), a commonly used gonococcal laboratory
strain that was isolated from a patient with uncomplicated
gonorrhea (33), also contained the Val-57-to-Met mutation,
along with an AN3QT double mutation at residues 2 and 3
(Fig. 1). To verify that the Val-57-to-Met mutation was respon-
sible for tetracycline resistance, we transformed PR100 with
MS11 DNA. As expected, MS11 DNA transformed PR100 to
tetracycline resistance at a high frequency (1  104), and
the MICs of these transformants were identical to those con-
structed with the isolated mutant rpsJ gene (data not shown).
Moreover, PCR and transformation experiments showed that
the Val-57-to-Met mutation and not the double mutation at
the second and third residues conferred resistance to tetracy-
cline. These data demonstrate that the mutant allele of rpsJ is
identical to tet-2, that it is present in MS11, and that resistance
is due to a single amino acid mutation at Val-57. This mutant
allele is referred to hereafter as rpsJ1.
Identification of rpsJ1 in tetracycline-resistant clinical iso-
lates. To determine the extent of the rpsJ1 allele in chromo-
somally mediated tetracycline-resistant strains, we amplified
and sequenced the rpsJ genes from a set of clinical isolates in
which the MIC of tetracycline was 2 g/ml but 8 g/ml.
Five of these strains, each with an MICtet of 2 g/ml, were from
a Wilson County, North Carolina, surveillance program carried
out from 1992 to 1994 (12), while three additional strains
(strains 111, 114, and 131), each with an MICtet of 4 g/ml,
were from an outbreak in Cincinnati, Ohio, in 1994. Each of
the strains examined contained an ATG codon at position 57,
identical to that found in FA6140 and MS11. No other differ-
ences were noted.
Spontaneous mutations in the rpsJ gene. To determine if we
could select for spontaneous rpsJ mutations in the laboratory,
we plated FA19 (1  109 CFU) on GCB plates containing
tetracycline at concentrations 1.2- to 1.8-fold higher than its
MIC, but no resistant colonies were observed. To increase the
frequency of mutation, we repeated the experiment with FA19
in which the mutS gene was deleted (28). Several hundred
small colonies growing on the plates were pooled, the rpsJ gene
was amplified from the genomic DNA of the pooled clones,
and the resulting fragments were used to transform FA19 to
tetracycline resistance. Whereas the rpsJ1 gene PCR product
gave rise to thousands of resistant colonies, no resistant trans-
formants were observed with the rpsJ gene amplified from the
pool of spontaneous mutants. These data suggest that the
frequency of spontaneous mutation in rpsJ is low and that the
rpsJ1 allele arose in the 1970s as a rare event and was then
disseminated throughout the species by homologous recombi-
nation.
High-level tetracycline resistance requires three genes. The
level of tetracycline resistance in N. gonorrhoeae depends on
the genetic background (30). To determine the effects of dif-
ferent resistance determinants in tetracycline resistance, we
transformed a series of strains with pMH-S10*, which harbors
the rpsJ1 allele (Table 1). The MICs of tetracycline for the
recipient strains FA19, FA19 penA4, and FA19 penA4 mtrR
were all identical (0.25 g/ml), while the MIC for strain PR100
(FA19 penA4 mtrR penB2) was 1.0 g/ml (Fig. 2). When the
rpsJ1 allele was introduced into the first three strains, the MIC
FIG. 1. Identification of the tet-2 gene as a mutation in the rpsJ gene encoding ribosomal protein S10. Clones capable of conferring tetracycline
resistance to PR100 (FA19 penA4 mtrR penB2; see Table 1) were isolated as described in Materials and Methods. Five separate clones each
contained a portion of the tufA gene and the entire rpsJ gene encoding S10. Transformation experiments with the two genes amplified by PCR
demonstrated that only the rpsJ gene was capable of conferring tetracycline resistance. Sequencing identified a single G3A mutation that changes
Val-57 to Met in the rpsJ gene from FA6140 (a CMRNG strain) compared to the sequence of FA19. The same mutation was found in the rpsJ
gene of MS11, a laboratory gonococcal strain (33), from a BLAST search of GenBank (accession number L36380).
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of tetracycline increased fourfold to 1 g/ml (Fig. 2). When the
rpsJ1 allele was introduced into PR100, which contains both
mtrR and penB2, resistance again increased fourfold (to 4 g/
ml). The MIC of tetracycline for PR100 rpsJ1 was identical to
that for FA6140, suggesting that mtrR, penB, and rpsJ1 are both
necessary and sufficient for strains to reach high-level chromo-
somally mediated tetracycline resistance.
We previously identified a spontaneous mutation in PR100,
termed penC, which increased the MIC of tetracycline twofold
(28), and have shown that resistance is due to a point mutation
in the pilQ gene (pilQ2) that interferes with the stability of the
PilQ secretin and decreases antibiotic influx (39). To examine
the influence of the pilQ2 mutation on tetracycline resistance
mediated by rpsJ1, we transformed PR100 pilQ2 with pMH-
S10* and determined the MIC of tetracycline of the resulting
strain. As shown in Fig. 2, the MIC of tetracycline for strain
PR100 pilQ2 increased threefold (from 2 to 6 g/ml) upon
acquisition of the rpsJ1 allele. Thus, irrespective of the genetic
background, the rpsJ1 determinant in N. gonorrhoeae increases
tetracycline resistance between three- and fourfold.
Role of residue 57 in mediating tetracycline resistance in
S10. To understand at a molecular level how mutations at
position 57 confer tetracycline resistance to N. gonorrhoeae, we
randomized the codon for Val-57 and used the resulting rpsJ
mutant PCR fragments to transform PR100 to increased tet-
racycline resistance. Twenty-two clones were isolated, and the
rpsJ genes from these isolates were amplified and sequenced.
From these 22 clones, three amino acids at position 57 were
identified: Met, Leu, and Gln. Each of these mutations con-
ferred identical levels of tetracycline resistance to PR100 (4
g/ml) or FA19 (1 g/ml), suggesting that large, uncharged
amino acids at this position increase tetracycline resistance and
that each of these amino acids affects resistance in an identical
manner.
Each of the amino acids identified in our randomized codon
screen were both large and hydrophobic, but because it was
possible that not all codons were represented in our random
screen, the necessity of having an amino acid that was both
large and hydrophobic was unclear. Thus, we employed site-
directed mutagenesis to change Val-57 to the large but charged
amino acid Lys, which is the residue found in this position in
the Thermus thermophilus S10 protein (Fig. 3A). Transforma-
tion of either FA19 or PR100 with the rpsJ gene containing the
Val-57-to-Lys mutation and selection on 1.1 to 2 times the
MIC of tetracycline did not yield resistant colonies at a rate
greater than that for the buffer controls, even though the rpsJ1
allele generated hundreds of resistant colonies in the same
experiment. These data demonstrate that the amino acid at
position 57 must be both large and hydrophobic to increase the
MIC of tetracycline in N. gonorrhoeae.
Proposed mechanism of rpsJ1-mediated tetracycline resis-
tance. Tetracycline is known to bind to the 30S ribosome near
the aminoacyl-tRNA binding site, thereby interfering with the
binding of aminoacyl-tRNAs and blocking peptide chain elon-
gation (29). Recently, high-resolution structures of the individ-
ual 30S and 50S ribosomal subunits and both subunits together
have provided significant insight into ribosomal function and
the mechanisms of inhibitors of protein synthesis (1, 37, 38). Of
particular relevance to this study is the 3.0-Å structure of the
Thermus thermophilus 30S ribosomal subunit bound with tet-
racycline (3, 4), which allows an examination at the structural
level of the potential effect of a mutation at Val-57 of ribo-
somal protein S10.
S10 is an elongated protein (63 Å in its longest dimension)
with two distinct regions: a mixed 	/ globular region at one
end of the protein and a long antiparallel  ribbon connected
by a large loop at the other end (Fig. 3B). In the 30S structure,
the loop at the end of the antiparallel  strands is situated near
the top of the groove that contains the aminoacyl- and pepti-
dyl-tRNA functional sites (A and P sites, respectively). In T.
thermophilus S10, Lys-55 is equivalent to Val-57 of S10 from N.
gonorrhoeae (Fig. 3A), and this residue is situated at the vertex
of the loop extending toward the A site of the 30S subunit. The
bound tetracycline is within 8.5 Å of the ε-NH2 group of Lys-55
(Fig. 3C), consistent with our results demonstrating that
changes in this amino acid influence the binding of the antibi-
otic. Although the side chain is probably too far removed to
cause a direct blocking of tetracycline binding, it is likely that
large, hydrophobic side chains at this position alter the RNA
structure in the vicinity of the bound tetracycline, hence de-
creasing the binding affinity of tetracycline.
DISCUSSION
Tetracyclines were one of the first “broad-spectrum” antibi-
otics developed, and although they remain useful for the treat-
ment of certain bacterial infections, their use has been seri-
ously compromised by the widespread emergence of resistant
strains. Most strains become resistant to tetracycline not by
mutations in RNA or ribosomal proteins but by the expression
of tetracycline-specific efflux pumps or by the production of
FIG. 2. MICs of tetracycline for gonococcal strains with different
genetic backgrounds. The open bars indicate the MIC of tetracycline
for each of the indicated parental strains (see Table 1 for more infor-
mation). The black bars indicate the MIC of tetracycline following
transformation of each strain with the rpsJ1 allele encoding S10 with a
Val-57-to-Met mutation. In each case, transfer of the rpsJ1 allele in-
creased tetracycline resistance by three- to fourfold. The MICs were
determined in three separate experiments with at least four individual
transformants for each strain; no variation in the MICs was observed
in the separate experiments.
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proteins (TetM and TetO) that mimic the elongation factors
and allow the release of the antibiotic from the ribosome (29).
N. gonorrhoeae, however, is an exception; in this organism
high-level chromosomally mediated resistance to tetracycline is
mediated by a combination of three gene mutations: (i) the
mtrR mutation, which results in overexpression of an nonspe-
cific efflux pump (MtrC-MtrD-MtrE) that promotes the efflux
of a range of hydrophobic agents and detergents; (ii) the penB
determinant, which is a mutated porin IB that decreases the
influx of tetracycline into the cell, and (iii) the rpsJ1 allele,
which we have characterized in this study (Fig. 4). In addition,
the penC (pilQ2) resistance determinant also increases tetra-
cycline resistance, but the clinical significance of this mutation
remains unproven (28). Of these, only the rpsJ1 determinant is
specific for tetracycline resistance, making it the first resistance
gene specific for this antibiotic in chromosomally mediated
tetracycline-resistant gonococcal strains. Although the combina-
tion of these mutations does not confer a level of tetracycline
resistance as high as that observed with tetracycline-specific
efflux pumps or the TetM determinant, the mtrR-penB-rpsJ1
FIG. 3. Proposed structural mechanism of the rpsJ1 mutation for increasing tetracycline resistance. (A) Sequence alignment of S10 from N.
gonorrhoeae (Ngo), B. subtilis (Bsu), and T. thermophilus (Tth) using ClustalX (18). The small arrow identifies the position of the Lys-46-to-Glu
mutation in B. subtilis that confers tetracycline resistance, while the larger arrow indicates the position of the Val-57 to Met mutation in N.
gonorrhoeae characterized in this study. (B) A low-magnification view of the 30S ribosomal subunit structure from T. thermophilus (3) showing the
rRNA backbone (gray) and the S10 protein (red). Also shown is the mRNA decoding site (marked by nucleotides A1492 and A1493) (4) and the
major binding site of tetracycline. The two residues indicated in S10, Val-44 and Lys-55 (shown in Corey-Pauling-Koltum [CPK] format), are
equivalent to Lys-46 of B. subtilis and Val-57 of N. gonorrhoeae, respectively. (C) A closer view of the small subunit showing rRNA helices H31
(green) and H34 (blue) that form the binding site for tetracycline along with the S10 ribosomal protein. Lys-55 forms contacts with H31 and H34.
Panels B and C were made with molscript (20) and Raster3d (22).
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gene triad is highly effective and provides levels of resistance
above those clinically achievable at the site of infection.
Our results indicate that the rpsJ1 allele acts independently
of other resistance factors and increases the MIC of tetracy-
cline between three- and fourfold, no matter what the genetic
background. In contrast, the other determinants involved in
tetracycline resistance, mtrR, penB, and penC, increase tetra-
cycline resistance only in certain backgrounds. For example,
the MIC of tetracycline does not increase in strains upon
acquisition of either the mtrR or penB resistance determinants
alone but increases only when both resistance determinants are
present (25, 30, 34). Likewise, the penC mutation does not
increase tetracycline resistance unless both mtrR and penB are
already present (39). The differences between rpsJ1 and the
other determinants likely reflect the fact that rpsJ1 acts directly
at the site of action of tetracycline, thereby increasing resis-
tance by a similar amount beyond the existing level in the
parental strain. In contrast, the other determinants all act by
limiting the concentration of tetracycline in the cell, and there
appears to be a synergism between the MtrC-MtrD-MtrE ef-
flux pump and the porin IB protein such that both genes are
necessary to decrease cellular levels of tetracycline (25).
The mechanism by which the rpsJ1 mutation arose and prop-
agated throughout the species appears to be different from that
for the penA resistance determinant. In penA-mediated resis-
tance, interspecies recombination and horizontal transfer have
resulted in a large array of different mutant penA alleles (2, 17,
32), such that the coding sequences of resistant penA alleles
differ from those of wild-type strains even in positions that do
not change the protein sequence. In contrast, the same Val-
57-to-Met mutation was observed in multiple strains with dis-
tinct geographical locations that were isolated from the late
1970s through 1994. Interestingly, both Gln and Leu confer
similar levels of resistance, but these changes were not ob-
served in any of the clinical isolates. Because we were unable
to readily select spontaneous mutations of the rpsJ gene in the
laboratory, it seems reasonable to assume that the Val-57-to-
Met mutation was a rare spontaneous mutation in an early
isolate from the 1970s (when chromosomally mediated tetra-
cycline resistance emerged) that then disseminated throughout
the species by horizontal transfer. A similar mechanism is
likely to have occurred with the ponA1 allele encoding PBP 1,
which has a single-base-pair mutation (and subsequent amino
acid change) within 2,400 bp of coding sequence (28).
FIG. 4. Schematic showing the various ways in which chromosomally mediated genes can increase tetracycline resistance. The colored boxes
represent the various resistance genes discussed in the text. Chromosomally mediated clinical isolates that are classified as tetracycline resistant
(MICtet  2 g/ml) contain the penB, mtrR, and rpsJ1 resistance determinants. The MICs of resistant strains shown at the bottom are approximate;
the actual MICs depend on which mtr mutation (14) and penB allele (24) are present. See the text for details.
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In the absence of a high-resolution structure of the 30S
ribosomal subunit from N. gonorrhoeae, the exact molecular
mechanism by which the Val-57-to-Met mutation increases
resistance to tetracycline cannot be conclusively proven. How-
ever, given the reasonably high level of homology between the
T. thermophilus and N. gonorrhoeae S10 proteins (55% identity,
75% similarity), crystal structures of the 30S subunit from T.
thermophilus provide a useful framework for understanding the
effect of this mutation. In the structure of the 30S subunit in
complex with tetracycline, the primary binding site of the an-
tibiotic is observed in the A site, which comprises the RNA
helices H31, H34, and H44 (Fig. 3C) (3). Although this site is
formed exclusively by RNA, the surrounding ribosomal pro-
teins, including S4, S6, and S14 as well as S10, presumably help
maintain its precise architecture. From sequence alignments
(Fig. 3A), Lys-55 in S10 from T. thermophilus is equivalent to
Met-57 of gonococcal S10. Lys-55 is located at the apex of a
large  ribbon, which points toward the tetracycline-binding
site and contacts both H31 and H34. This residue is too distant,
however, for any mutation to clash directly with tetracycline.
Instead, such a mutation would likely perturb the local rRNA
structure within this region by altering the contacts between
S10 and the RNA helices H31 and H34. Importantly, such a
modulation of RNA structure must lower the affinity of rRNA
for tetracycline without any deleterious effects on protein syn-
thesis. A similar scenario applies to other chromosomally me-
diated resistance genes, where a narrow window exists in which
the gene mutation increases resistance without significantly
disrupting the normal function of the protein. For example,
mutations in the penA gene decrease the ability of PBP 2 to be
inhibited by penicillin but do not prevent its normal function of
peptide cross-linking.
Only one previous study has identified a mutation in a ribo-
somal protein that gives rise to tetracycline resistance. Wil-
liams and Smith (36) identified a tetracycline-resistant strain of
Bacillus subtilis following ethyl methanesulfonate mutagenesis
that showed an altered mobility of the ribosomal protein S10
on two-dimensional gel electrophoresis. This mutation was
subsequently mapped to a Lys-46-to-Glu alteration in S10 (35).
These data are consistent with a role of S10 in tetracycline
binding, although the mutations are in distinct regions of the
protein. The mutation in the B. subtilis S10 protein maps onto
the antiparallel  ribbon of the T. thermophilus S10 structure
toward the globular domain (Fig. 3A and B), but the mutation
site is not in a conserved residue (its equivalent in T. ther-
mophilus S10 is Val-44) and its role in ribosomal structure is
difficult to predict. Surprisingly, the Lys-46-to-Glu mutation in
B. subtilis S10 confers high levels of resistance to tetracycline
(
50 g/ml) relative to that conferred by the Val-57-to-Met
mutation in gonococcal S10 (36). This suggests that the B.
subtilis mutation causes a much more significant perturbation
to the tetracycline-binding site on the ribosome than the rpsJ1
mutation. Consistent with this hypothesis, colonies with the
Lys-46-to-Glu mutation grew considerably slower than wild-
type cells (36), suggesting that the mutation causes a disruption
in the positioning of the S10 protein in the ribosome and a
subsequent decrease in the rate of protein synthesis.
In summary, our results show that tet-2, a determinant as-
sociated with chromosomally mediated tetracycline resistance,
is a mutation in the rpsJ gene (rpsJ1) that encodes ribosomal
protein S10. Thus, in chromosomally mediated tetracycline-
resistant isolates, three resistance determinants, mtrR, penB,
and rpsJ1, are both necessary and sufficient to achieve high-
level tetracycline resistance. The MIC of tetracycline for spe-
cific isolates differs according to which of these determinants
are present (Fig. 4). In addition, the MIC can also differ de-
pending on the type of mtr mutation (strains with deletions or
mutations in the mtrR transcriptional regulator are less resis-
tant to a variety of hydrophobic agents than strains with a
single-base-pair deletion in the mtrR promoter region) and on
which penB allele is present (14, 24). In contrast to mtrR and
penB, which also contribute to penicillin resistance, the rpsJ1
allele is specific for tetracycline resistance and likely acts di-
rectly by lowering the affinity of the ribosome for the antibiotic
through alteration of its binding site. These results highlight
the complex mechanisms by which gonococcal strains become
resistant to tetracycline.
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